Clinical Trials Logo

Clinical Trial Summary

The investigators aim to determine if dry needling technique in a non myofascial trigger point area generate the same spasticity, function and pain answers as carrying it out in a myofascial trigger point area.

In the same way, the investigators aim to prove how much the effect lasts with an only intervention.

Clinical Trial Description

Spasticity is a consequence of multiple diseases that affect the Central Nervous System, such as stroke and other neurodegenerative diseases. Its pathophysiology is unclear and the variety of its clinical symptoms is determined by the injurie's different locations.

Several studies suggest the possibility of active pain treatment effectiveness through myofascial trigger points treatment. One of these is dry needling, which has been used in several scientific studies. However, these investigations have been based on spasm response or deep dry needling mechanisms, but none of the participants compare the possible mechanic effects of the insertion of a needle into a spastic muscle.

Therefore, the aim of this study is to evaluate the effects on spasticity, pain and motor function after a dry needling intervention versus the insertion of a needle into a non trigger point muscle in neurological damage patients. It also attempts to register in a calendar the dry needling effect duration when changes are being observed. ;

Study Design

Related Conditions & MeSH terms

NCT number NCT03906305
Study type Interventional
Source Universidad Rey Juan Carlos
Status Active, not recruiting
Phase N/A
Start date November 26, 2018
Completion date December 30, 2019

See also
  Status Clinical Trial Phase
Recruiting NCT03281590 - Stroke and Cerebrovascular Diseases Registry
Recruiting NCT03728738 - Zero Degree Head Positioning in Hyperacute Large Artery Ischemic Stroke Phase 3
Recruiting NCT03396419 - IMPACT- 24col Collateral Blood Flow Assessment Following SPG Stimulation in Acute Ischemic Stroke (ImpACT-24B Sub-Study)
Recruiting NCT02910180 - Genetic, Metabolic, and Growth Factor Repository for Cerebrovascular Disorders N/A
Recruiting NCT03554642 - Walkbot Robotic Training for Improvement in Gait Phase 3
Withdrawn NCT01866189 - Identification of Hypoxic Brain Tissues by F-MISO PET in Acute Ischemic Stroke N/A
Completed NCT02922452 - A Study to Evaluate the Effect of Diltiazem on the Pharmacokinetics (PK) of BMS-986141 in Healthy Subjects Phase 1
Recruiting NCT03041753 - Reperfusion Injury After Stroke Study N/A
Completed NCT02549846 - AdminiStration of Statin On Acute Ischemic stRoke patienT Trial Phase 4
Completed NCT01678534 - Reparative Therapy in Acute Ischemic Stroke With Allogenic Mesenchymal Stem Cells From Adipose Tissue, Safety Assessment, a Randomised, Double Blind Placebo Controlled Single Center Pilot Clinical Trial Phase 2
Completed NCT02610803 - Paroxysmal Atrial Fibrillation in Patients With Acute Ischemic Stroke N/A
Completed NCT02924168 - Radial Shock Waves for Functional Disability in Stroke N/A
Not yet recruiting NCT01923818 - Treatment of Rivaroxaban Versus Aspirin for Non-disabling Cerebrovascular Events Phase 2/Phase 3
Completed NCT01983644 - RECO Flow Restoration Device Versus Solitaire FR With the Intention for Thrombectomy Study N/A
Suspended NCT01852201 - POSITIVE Stroke Clinical Trial N/A
Completed NCT01968122 - Registry Study of Stenting for Symptomatic Intracranial Artery Stenosis in China N/A
Completed NCT02184936 - Measuring Collaterals With Multi-phase CT Angiography in Patients With Ischemic Stroke N/A
Completed NCT01949948 - Study of Tenecteplase Versus Alteplase for Thrombolysis (Clot Dissolving) in Acute Ischemic Stroke Phase 3
Recruiting NCT01526824 - Lovaza's Effect on Clopidogrel in a Neuro Population Phase 0
Completed NCT01193569 - A Study of Survival and Outcome After Stroke